These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Comparison of the efficacy and tolerability of pitavastatin and atorvastatin: an 8-week, multicenter, randomized, open-label, dose-titration study in Korean patients with hypercholesterolemia. Lee SH, Chung N, Kwan J, Kim DI, Kim WH, Kim CJ, Kim HS, Park SH, Seo HS, Shin DG, Shin YW, Shim WJ, Ahn TH, Ho Yun K, Yoon MH, Cha KS, Choi SW, Han SW, Hyon MS. Clin Ther; 2007 Nov; 29(11):2365-73. PubMed ID: 18158077 [Abstract] [Full Text] [Related]
28. Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation. Wissing KM, Unger P, Ghisdal L, Broeders N, Berkenboom G, Carpentier Y, Abramowicz D. Transplantation; 2006 Sep 27; 82(6):771-8. PubMed ID: 17006324 [Abstract] [Full Text] [Related]
29. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial. Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group. Clin Ther; 2004 Sep 27; 26(9):1388-99. PubMed ID: 15531001 [Abstract] [Full Text] [Related]
30. The influence of pravastatin and atorvastatin on markers of oxidative stress in hypercholesterolemic humans. Ky B, Burke A, Tsimikas S, Wolfe ML, Tadesse MG, Szapary PO, Witztum JL, FitzGerald GA, Rader DJ. J Am Coll Cardiol; 2008 Apr 29; 51(17):1653-62. PubMed ID: 18436117 [Abstract] [Full Text] [Related]
31. Randomised study to compare the efficacy and safety of isapgol plus atorvastatin versus atorvastatin alone in subjects with hypercholesterolaemia. Jayaram S, Prasad HB, Sovani VB, Langade DG, Mane PR. J Indian Med Assoc; 2007 Mar 29; 105(3):142-5, 150. PubMed ID: 17824470 [Abstract] [Full Text] [Related]
32. Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients. Sardo MA, Campo S, Bonaiuto M, Bonaiuto A, Saitta C, Trimarchi G, Castaldo M, Bitto A, Cinquegrani M, Saitta A. Curr Med Res Opin; 2005 May 29; 21(5):777-84. PubMed ID: 15969877 [Abstract] [Full Text] [Related]
33. Effects of switching statins on lipid and apolipoprotein ratios in the MERCURY I study. Cheung RC, Morrell JM, Kallend D, Watkins C, Schuster H. Int J Cardiol; 2005 Apr 20; 100(2):309-16. PubMed ID: 15823640 [Abstract] [Full Text] [Related]
34. Effects of atorvastatin on low-density lipoprotein cholesterol phenotype and C-reactive protein levels in patients undergoing long-term dialysis. Dornbrook-Lavender KA, Joy MS, Denu-Ciocca CJ, Chin H, Hogan SL, Pieper JA. Pharmacotherapy; 2005 Mar 20; 25(3):335-44. PubMed ID: 15843280 [Abstract] [Full Text] [Related]
35. High-dose atorvastatin improves hypercholesterolemic coronary endothelial dysfunction without improving the angiogenic response. Boodhwani M, Nakai Y, Voisine P, Feng J, Li J, Mieno S, Ramlawi B, Bianchi C, Laham R, Sellke FW. Circulation; 2006 Jul 04; 114(1 Suppl):I402-8. PubMed ID: 16820608 [Abstract] [Full Text] [Related]
36. Atorvastatin lowers plasma low-density lipoprotein cholesterol and C-reactive protein in Japanese type 2 diabetic patients. Yamada S, Yanagawa T, Sasamoto K, Araki A, Miyao M, Yamanouchi T. Metabolism; 2006 Jan 04; 55(1):67-71. PubMed ID: 16324921 [Abstract] [Full Text] [Related]
37. Efficacy and safety of rosuvastatin and atorvastatin in patients with hypercholesterolemia and a high risk of coronary heart disease: a randomized, controlled trial. Schwartz GG, Bolognese MA, Tremblay BP, Caplan R, Hutchinson H, Raza A, Cressman M. Am Heart J; 2004 Jul 04; 148(1):e4. PubMed ID: 15215813 [Abstract] [Full Text] [Related]
38. One-year atorvastatin treatment in hypercholesterolemic patients with or without carotid artery disease. Avellone G, Di Garbo V, Abruzzese G, Campisi D, De Simone R, Raneli G, Licata G. Int Angiol; 2006 Mar 04; 25(1):26-34. PubMed ID: 16520721 [Abstract] [Full Text] [Related]
39. Lectin-like oxidized-LDL receptor-1 (LOX-1) polymorphisms influence cardiovascular events rate during statin treatment. Puccetti L, Pasqui AL, Bruni F, Pastorelli M, Ciani F, Palazzuoli A, Pontani A, Ghezzi A, Auteri A. Int J Cardiol; 2007 Jun 25; 119(1):41-7. PubMed ID: 17050011 [Abstract] [Full Text] [Related]
40. The influence of low-dose atorvastatin on lipid levels and endothelial vascular function in patients with significant coronary artery stenosis. Kuryata OV, Yegorova YV. Kardiol Pol; 2006 Jan 25; 64(1):44-8; discussion 49-50. PubMed ID: 16444629 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]